ÂÜÀòÂÒÂ×

Tim (Tingxi) Guo is a Senior Scientist at GentiBio since September 2021, with previous roles as Scientist II and Scientist I. Prior to GentiBio, Tim served as a Postdoctoral Associate at the Massachusetts Institute of Technology from October 2019 to August 2021, where a synthetic promoter was developed to enhance the specificity and potency of TCR/CAR-engineered T cell therapies. Tim's earlier experience includes a PhD Candidate/Postdoctoral Researcher position at the University Health Network from September 2013 to August 2019, focusing on the characterization of antigen recognition of non-classical MHC by TCRs and the anti-tumor efficacy of mesothelin-specific CAR T cells. Tim obtained a Doctor of Philosophy in Immunology from the University of Toronto in 2018 and completed an Honours Bachelor of Science in Immunology from the same institution in 2013.